[1]Echeverria V, Echeverria F, Barreto GE, et al. Estrogenic plants: to prevent neurodegeneration and memory loss and other symptoms in women after menopause [J]. Front Pharmacol, 2021, 12: 644103.
[2]Gurvich C, Le J, Thomas N, et al. Sex hormones and cognition in aging [J]. Vitam Horm, 2021, 115: 511-533.
[3]Zhang N, Cui Y, Li Y, et al. A novel role of nogo proteins: regulating macrophages in inflammatory disease [J]. Cell Mol Neurobiol, 2022, 42(8):2439-2448.
[4]Seiler S, Di Santo S, Widmer HR. Nogo-A neutralization improves graft function in a rat model of parkinson’s disease [J]. Front Cell Neurosci, 2016, 10: 87.
[5]Tang H, Xu Y, Liu L, et al. Nogo-A/S1PR2 signaling pathway inactivation decreases microvascular damage and enhances microvascular regeneration in PDMCI mice [J]. Neuroscience, 2020, 449: 21-34.
[6]Spencer SJ, D’Angelo H, Soch A, et al. High-fat diet and aging interact to produce neuroinflammation and impair hippocampal-and amygdalar-dependent memory [J]. Neurobiol Aging, 2017, 58: 88-101.
[7]Wang W, Bai W, Cui G, et al. Effects of estradiol valerate and remifemin on norepinephrine signaling in the brain of ovariectomized rats [J]. Neuroendocrinology, 2015, 101 (2): 120-132.
[8]Cora MC, Kooistra L, Travlos G. Vaginal cytology of the laboratory rat and mouse: review and criteria for the staging of the estrous cycle using stained vaginal smears [J]. Toxicol Pathol, 2015, 43 (6): 776-793.
[9]Maffei S, Franchini M, Fortunato L, et al. Long-term effects of a combination of isoflavones, agnus castus and magnolia extracts on climacteric symptoms and cardiometabolic risk profile in postmenopausal women [J]. Gynecol Endocrinol, 2022, 38 (4): 339-344.
[10]Sourouni M, Zangger M, Honermann L, et al. Assessment of the climacteric syndrome: a narrative review [J]. Arch Gynecol Obstet, 2021, 304 (4): 855-862.
[11]Marchant IC, Chabert S, Martínez-Pinto J, et al. Estrogen, cognitive performance, and functional imaging studies: what are we missing about neuroprotection [J]? Front Cell Neurosci, 2022, 16: 866122.
[12]Soto A, Nieto-Díaz M, Reigada D, et al. miR-182-5p regulates Nogo-A expression and promotes neurite outgrowth of hippocampal neurons in vitro [J]. Pharmaceuticals (Basel), 2022, 15(5):529-542.
[13]Shimojo GL, da Silva Dias D, Malfitano C, et al. Combined aerobic and resistance exercise training improve hypertension associated with menopause [J]. Front Physiol, 2018, 9: 1471.
[14]Cai C, Wang L, Li S, et al. Ras inhibitor lonafarnib rescues structural and functional impairments of synapses of Aβ(1-42) mice via α7nAChR-dependent BDNF upregulation [J].J Neurosci, 2022, 42(31):6090-6107.
[15]Cohen HS, Lincoln CM, Pavlik VN, et al. Changes in measures of vestibular and balance function and hippocampus volume in alzheimer’s disease and mild cognitive impairment [J]. Otol Neurotol, 2022, 43(6):e663-e670.
[16]Delekate A, Zagrebelsky M, Kramer S, et al. NogoA restricts synaptic plasticity in the adult hippocampus on a fast time scale [J]. Proc Natl Acad Sci USA, 2011, 108 (6): 2569-2574.
[17]Gil V, Nicolas O, Mingorance A, et al. Nogo-A expression in the human hippocampus in normal aging and in Alzheimer disease [J]. J Neuropathol Exp Neurol, 2006, 65 (5): 433-444.
[18]Wang ZhL, Zhang Y, Wang J. Role of Nogo-A and Nogo-A receptors in Alzheimer’s disease [J]. Acta Annatomica Sinica, 2018,49(4):549-555. (in Chinese)
王兆伦,张艳,王君. Nogo-A及其受体在阿尔茨海默病中的作用[J].解剖学报,2018,49(4):549-555.
[19]Kress GJ, Yamawaki N, Wokosin DL, et al. Convergent cortical innervation of striatal projection neurons [J]. Nat Neurosci, 2013, 16 (6): 665-667.
[20]Marino RA, Gaprielian P, Levy R. Systemic D1-R and D2-R antagonists in Non-human primates differentially impact learning and memory while impairing motivation and motor performance [J]. Eur J Neurosci, 2022, 56(3):4121-4140.
[21]Ryu H, Lee J, Zaman K, et al. Sp1 and Sp3 are oxidative stress-inducible, antideath transcription factors in cortical neurons [J]. J Neurosci, 2003, 23 (9): 3597-3606.
[22]Waters EM, Yildirim M, Janssen WG, et al. Estrogen and aging affect the synaptic distribution of estrogen receptor β-immunoreactivity in the CA1 region of female rat hippocampus [J]. Brain Res, 2011, 1379: 86-97.
[23]Baraka AM, Korish AA, Soliman GA, et al. The possible role of estrogen and selective estrogen receptor modulators in a rat model of Parkinson’s disease [J]. Life Sci, 2011, 88 (19-20): 879-885.
|